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Abstract
Background: The aim of the present study was to assess the prevalence and resistance of commensal S. aureus
in the nasal microbiota of community-dwelling persons in Austria, as well as to identify possible associations with
socio-demographic factors. Multi-drug resistance in this population was additionally studied.
Method: This cross-sectional study was conducted within the context of the European APRES project. In nine
European countries, nasal swabs were collected from 32,206 general practice patients who received care for
non-infectious reasons. In Austria, 20 GPs attempted to recruit 200 consecutive patients without infectious diseases, with
each patient completing demographic questionnaires as well as providing a nose swab sample. Isolation, identification,
and resistance testing of S. aureus were performed. Statistical analyses included subgroup analyses and logistic regression
models.
Results: 3309 nose swabs and corresponding questionnaires from Austrian subjects were analyzed. S. aureus was
identified in 16.6 % (n = 549) of nose swabs, of which 70.1 % were resistant against one or more antibiotics, mainly
penicillin. S. aureus carrier status was significantly associated with male sex (OR 1.6; 1.3–2.0), younger age (OR 1.3;
1.0–1.8), living in a rural area (OR 1.4; 1.1–1.7) and working in the healthcare sector (OR 1.5; 1.0–2.1). Multi-drug resistances
were identified in 13.7 % (n = 75) of the S. aureus carriers and 1.5 % (n = 8) tested positive for MRSA. The highest resistance
rate was observed against penicillin (64.8 %), followed by azithromycin (13.5 %) and erythromycin with 13.3 %.
Conclusion: This study describes the prevalence and resistance patterns of commensal S. aureus in community-dwelling
persons in Austria and shows that differences exist between socio-demographic groups. Demographic associations have
been found for S. aureus carriers but not for carriers of resistant S. aureus strains. Only two thirds of S. aureus strains were
found to be resistant against small spectrum penicillin. As it is recognized that one of the corner stones for the
containment of antibiotic resistance is the appropriate prescription of antibiotics in the outpatient sector, this
finding lends support to the avoidance of prescription of broad-spectrum antibiotics to treat S. aureus infections in the
community.
Keywords: Staphylococcus aureus, MRSA, Commensal antibiotic resistances, Primary health care, Austria
* Correspondence: kathryn.hoffmann@meduniwien.ac.at
1Department of General Practice and Family Medicine, Centre for Public
Health, Medical University of Vienna, Kinderspitalgasse 15/1st floor, 1090
Vienna, Austria
Full list of author information is available at the end of the article
© 2015 Hoffmann et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hoffmann et al. BMC Infectious Diseases  (2015) 15:213 
DOI 10.1186/s12879-015-0949-1
Background
One of the major challenges for healthcare systems
around the world is the growing prevalence of antibiotic
resistance (AR) [1]. The World Health Organization’s
2014 report on AR began with an introductory statement
that raised concern for, “A post-antibiotic era—in which
common infections and minor injuries can kill—far from
being an apocalyptic fantasy, is […] a very real possibility
for the 21st century.[1]” AR is known to be associated with
an increased morbidity and mortality [1–6]. At least
four reasons for recent increasing rates in AR have been
suggested: 1) the excessive use of antibiotics by humans,
including antibiotic overtreatment fostered by over-the-
counter selling of antibiotics and inappropriate prescrip-
tions of antibiotics for viral infections [1, 7–10], 2)
influences of travelling [11], 3) the excessive use of an-
tibiotics in livestock breeding [1, 12–15], and 4) the
stagnancy in development of new generations of anti-
biotics [1, 16]. Together, this has led to a large output
of resistant bacteria into the environment, where re-
sistance genes can disseminate easily [1, 17–19]. These
factors for AR imply that community exposures and ambu-
latory care have a large impact on acquisition and resist-
ance. However, the majority of existing information on
antibiotic resistance pattern has been obtained from
hospitalized patients, rather than from samples of
community-dwelling persons [9, 20, 21]. Given that
community-acquired AR differ from patterns observed
in hospitalized patients, identifying the prevalence and
resistance in the general population would provide an
important source of knowledge on the acquisition of
resistance in pathogens [1].
While S. aureus is a common part of the normal human
microbiota, it is also often found to be responsible for sev-
eral severe infections [22–24]. S. aureus is of particular
interest due to its special capacity to acquire resistance, as
exemplified by the recent steep increase in AR levels of
S. aureus strains against penicillin [25]. Furthermore,
circumstances such as the increasing prevalence of
methicillin-resistant S. aureus (MRSA) that result in lim-
ited treatment options, continue to press the growing
international concern and need for surveillance of the
situation in the non-hospitalized setting [1, 26, 27].
In the context of the EU-project “APRES – the ap-
propriateness of prescribing antibiotics in primary
health care in Europe with respect to antibiotic resist-
ance” [28], it was our aim to gain detailed information
about the prevalence and resistance of commensal S.
aureus of community-dwelling GP patients in Austria.
Specifically, we aimed to evaluate a community popu-
lation for nasal S. aureus carriage and to observe any
associations with socio-demographic data, as well as
to assess for multi-drug resistance. Moreover, we per-
formed subgroup-analyses on those patients carrying
S. aureus with resistance to any antibiotic aside from
penicillin, as this group may be associated with higher
risks for acquiring AR and multi-drug resistances.
Methods
Design
This cross-sectional study took place in the context of the
European APRES project, which included nine European
countries and a methodology that has been described in
depth in several publications [8, 28–30]. Therefore, we
describe in this publication only the methods relevant
for Austria. [22] The study analysis was designed in ac-
cordance with the STROBE statement for cross-sectional
studies [31].
Recruitment of study participants in Austria
First, twenty general practitioners (GPs) were recruited via
electronic invitation by the Austrian Society of General
Practice and the research network of the Department of
General Practice at the Medical University of Vienna. In
line with the APRES project, those recruited constituted a
fair representation of the national GP population with re-
gard to sex, age and federal state [32]. Additionally, GP
demographics were included in this study. Between
November 2010 and July 2011 these twenty GPs were
asked to identify 200 consecutive patients aged four
years and older. Detailed inclusion and exclusion cri-
teria for the patients were published elsewhere [28,
30]. Most important for this analysis was the exclusion
criterion that the patients’ consultation had to be due
to a non-infectious disease and that the patients did
not take antibiotics for a minimum of three months
prior to the study. Additional important exclusion criteria
included those living in a nursing home, those with any
hospitalization in the three month period prior to the
study, the immunocompromised, and all those aged less
than 4 years. A nose swab was collected and each patient
then completed two questionnaires regarding their socio-
demographic data. Among this was the APRES patients’
questionnaire and an additional questionnaire designed by
the Department of General Practice at the Medical
University of Vienna, with further questions relating
to demographics. The additional questionnaire is de-
scribed in detail in the publication of Hoffmann et al.
[30]. For those patients between four and 14 years, a
parent completed the questionnaires to ensure the re-
liability of the data.
Material
The nose swabs were sent within 24 hours to the na-
tional laboratory (Institute of Hygiene, Microbiology
and Tropical Medicine, Elisabethinen Hospital, Linz,
Austria) for the identification and isolation of S. aur-
eus. Charcoal swabs were used as transport medium
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(Transystem, 114 C; Copan Italia, Brescia, Italy). The
swabs were sent to the laboratory using special enve-
lopes to ensure security and fast delivery of the swabs.
All laboratories used standardized protocols for the
identification of S. aureus [28]. Those swabs that were
found to have isolated S. aureus strains were sent to
the APRES central laboratory for further AR testing.
All AR testing was performed in accordance with the
European Committee on Antimicrobial Susceptibility
Testing (EUCAST) guidelines and EUCAST epidemio-
logical cut-offs were used as breakpoints [33]. Antimicro-
bial susceptibility testing was performed for multiple
antibiotics, including, azithromycin (AZITH), ciprofloxa-
cin (CIP), clindamycin (CLIND), daptomycin (DAPT),
erythromycin (ERY), gentamicin (GENTA), linezolid (LIN),
oxacillin (OXA), penicillin (PEN), tetracyclin (TETRA),
trimethoprim-sulfamethoxazole (TRISUL), and vancomycin
(VANC). S. aureus ATCC 29213 was used as control strain.
All isolates susceptible to CLIN and resistant to ERY were
tested for inducible CLIIN resistance by means of the
D-test [34]. In the case of a positive D-test, strains were
considered resistant to CLIN. Additionally, the pres-
ence of MRSA strains was evaluated. The MRSA resist-
ance screening was previously described in detail by
den Heijer et al [8].
Multi-drug resistance was defined as a S. aureus strain
that was resistant to three or more antibiotics.
Patients’ information
Patient information in the two questionnaires used for
this study included sex, age, educational level, country
of origin, location of residence, and profession. Age
was clustered into four groups: age 4-18 years (children),
19–39 years (young adults), 40–64 years (older adults),
and 65 years and older (elderly). The highest educational
level attained was surveyed in three groups: primary,
secondary and tertiary education. Tertiary education
was defined as completion of university or any further or
post graduate education. Country of origin was assessed
with the question “What is your country of origin?” This
variable was grouped into four clusters: 1) Austria, 2)
European Union (EU) 15 countries including European
Free Trade Association (EFTA) countries (EU15+), 3)
new EU 28 countries (EU28), and 4) all other countries.
Location of residence was dichotomized into urban
areas (big and intermediate cities) and rural areas (small
cities, villages and countryside). Classification of the area
was applied by using the European DEGURBA (degree of
urbanization) classification [35]. Profession was assessed by
“Do you work in any of the following occupational fields?”
with the answer categories “healthcare”, “livestock farming”,
“kindergarten teacher/ (day) nanny”, or “others”. All socio-
demographics were defined as independent variables.
Data analyses
The initial analysis was carried out for the distribution of
socio-demographic data for all patients, S. aureus carriers,
S. aureus carriers with antibiotic resistance to any anti-
biotic as well as any antibiotic besides PEN, and those car-
riers of MRSA. This was performed using descriptive
statistical methods (absolute and relative frequencies and
cross-tabs) and the Chi-Square Independency or Fisher’s
Exact test for categorical variables. If independency could
not be proven, the two-proportion z-test to compare two
or more column proportions including the Bonferroni
method for multiple testing was used to determine which
particular categories were not independent. Next, multi-
variable logistic regression models were conducted [36]. In
the first regression model, S. aureus carrier status was the
dependent variable, while those S. aureus carriers with AR
were recognized as the dependent variable for the second
regression model and those with AR besides PEN for the
third model. All socio-demographic variables were in-
cluded simultaneously in the model and a backward re-
gression model was performed. Variables were excluded at
a level of 0.20. We chose a p-value cut-off point of 0.2 for
the backward selection as more traditional levels, such as
0.05, can fail to identify variables known to be important
[37, 38]. This was followed by purposeful testing of even-
tual missed effects of the excluded variables. This step can
be helpful in identifying variables that, by themselves, are
not significantly related to the outcome, yet make an im-
portant contribution in the presence of other variables. At
the end of this final step, the preliminary main effects
model could be analyzed [37]. Additionally, the regression
models were adjusted for GP practice code to account for
any possible inter-practice effect. This was performed by
building a dichotomous dummy variable for each GP prac-
tice, which was included in the models.
Then, the number of resistances of S. aureus against AB
was assessed and the distribution of the socio-demographic
variables in relation to the number of antibiotics resistant
to S. aureus calculated by means of descriptive statistical
methods.
The significance level for all calculations was p < 0.05
and the confidence interval was 95 %. SPSS Statistics
version 22.0 was used for the statistical analyses.
Ethical considerations
The study was approved by the Ethics Committee of the
Medical University of Vienna (EC # 568/2010).
Each participant had to complete a written informed
consent form prior to participation. If the patient was
younger than 18 years, both a parent and the child each
completed written informed consent forms. Those aged 4
to 13 completed a special consent form for children, while
those aged 14 to 18 completed a form for adolescents.
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Results
Altogether, 3380 nose swabs of GP patients were col-
lected in Austria. Of those, 3309 were eligible for this
analysis because patients met the inclusion criteria and
had complete S. aureus and questionnaire data. The dis-
tribution of the socio-demographic data for the whole
sample is described in Table 1. S. aureus was identified
in 16.6 % (n = 549) of patients’ nasal swabs, of which
70.1 % (n = 385) of the S. aureus found were resistant to
one or more antibiotics. MRSA was identified in 1.5 %
(n = 8) of S. aureus carriers (8). The highest resistances
were observed to PEN with 64.8 % (n = 356), followed by
AZITH with 13.5 % (n = 74), ERY 13.3 % (n = 73),
CLIND 11.1 % (n = 61), TETRA 3.5 % (n = 19), GENTA
2.2 % (n = 12), CIP 1.5 % (n = 8), OXA 1.5 % (n = 8), and
TRISUL with 0.2 % (n = 1).
Prevalence of S. aureus, resistance, MRSA and
socio-demographic factors
Table 1 shows the distribution of the socio-demographic
factors within the S. aureus carrier group, the group of
carriers with AR, the group of carriers with AR besides
PEN, and the MRSA group. Males, younger adults and
those living in the countryside showed a statistically
Table 1 Distribution of the socio-demographic variables among S. aureus carriers, carriers with resistances and MRSA carriers
Variable Sub-variable All S. aureus carrier S. aureus carrier
with resistances
S. aureus carrier with
resistances (besides PEN)
MRSA carrier
% (n) % (n) % (n) % (n) % (n)
All 100 (3309) 16.6 (549) 70.1 (385) 64.8 (356) 1.5 (8)
Sex Female 56.6 (1862)a 13.9 (257)a 72.8 (187) 66.1 (170)a 2.3 (6)
Male 43.6 (1428)b 20.3 (288)b 68.4 (197) 64.2 (185)a 0.7 (2)
p <0.001 <0.001 0.235 0.640 0.234
Age 4–18 4.2 (139) 20.1 (28)a 71.4 (20) 67.9 (19) 0
19–39 27.6 (913)a 18.2 (166)a,b 74.1 (123) 71.1 (118) 2.4 (4)
40–64 45.1 (1493)b 16.8 (251)a,b 68.5 (172) 62.2 (156) 1.2 (3)
65+ 23.1 (764)c 13.6 (251)b 67.3 (70) 60.6 (63) 1.0 (1)
p <0.001 0.043 0.580 0.206 0.651
Educational level Primary 49.0 (1580)a 16.9 (265) 69.4 (184) 65.3 (173) 0.4 (1)
Secondary 37.3 (1203)b 16.2 (194) 69.1 (134) 62.9 (120) 1.5 (3)
Tertiary 13.7 (442)c 16.8 (74) 70.3 (52) 64.9 (48) 5.4 (4)
p <0.001 0.891 0.991 0.741 0.018
Country of origin
Austria 86.0 (2806)a 16.7 (467) 69.0 (322) 63.6 (297) 1.5 (7)
EU 15+ 3.2 (103)b 21.6 (22) 77.3 (17) 72.7 (16) 0
New EU 28 2.8 (94)b 18.1 (17) 76.5 (13) 70.6 (12) 5.9 (1)
Others 7.9 (259)b 14.0 (36) 75.0 (27) 69.4 (25) 0
p <0.001 0.352 0.742 0.688 0.698
Location of residence
Urban 43.9 (1461)a 13.8 (200)a 67.2 (135) 59.2(119)a 1.5 (3)
Rural 56.1 (1867)b 18.8 (345)b 71.8 (250) 68.1 (237)b 1.4 (5)
p <0.001 <0.001 0.287 0.035 0.828
Job
Health care 5.8 (194)a,b 21.6 (42) 71.4 (30) 64.3 (27) 7.1 (3)
Livestock farming 2.9 (96)b 16.7 (16) 62.5 (10) 56.3 (9) 0
Kindergarten teacher/nanny 1.9 (62)b 11.3 (7) 85.7 (6) 85.7 (6) 0
p Others 78.8 (2621)c 16.5 (431) 70.3 (303) 64.7 (279) 0.9 (4)
Not known 10.7 (355)a,b 15.7 (53) 67.9 (36) 66.0 (35) 1.9 (1)
<0.001 0.302 0.866 0.755 0.119
a,b,The subscript letters represent a subset of the variable category which is not significantly different at a significance level of p < 0.05 if it is the same subscript
for the same sub-variable
Significance at significance level of p < 0.005
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significant increased likelihood to be S. aureus carriers.
Additionally, Table 1 shows that 64.8 % of the S. aureus
carriers had resistances aside from PEN. These cases
were more frequent in persons living in rural areas.
The number of MRSA carriers was too small to de-
tect serious differences in socio-demographics. Also for
S. aureus carriers with resistance to one or more antibi-
otics, no differences in the socio-demographics could
be found.
In the first adjusted multivariable logistic regression
model, positive associations with S. aureus carrier status
could be found for those of the male sex, between the
age of 19 and 39 years, living in an rural area, and work-
ing in the health care sector (Table 2). Additionally, in
the third adjusted model living in a rural area was found
to increase the probability of being a S. aureus carrier
with resistances besides PEN (Table 2).
Multidrug-resistance of S. aureus and associations with
socio-demographic factors
If S. aureus strains were resistant to three or more anti-
biotics, nearly all were resistant to PEN, AZITH, ERY,
and CLIND (Table 3). S. aureus strains that were resist-
ant against PEN most commonly demonstrated isolated
resistant against PEN, but did show secondary resis-
tances against three other AB, mainly AZITH, ERY and
CLIND (Table 4). Out of the MRSA strains, five were re-
sistant against other AB besides OXA and PEN (Table 5).
Of all S. aureus carriers, with the exception of MRSA
carriers, 13.7 % (n = 72) were identified as multi-drug re-
sistant strains. Persons living in urban areas were found
to have significantly more frequent multi-drug resistant
strains (Table 6).
Discussion
The present study evaluated the prevalence and resist-
ance patterns of commensal nasal S. aureus strains from
urban and rural GP patients in Austria. The results sub-
sequently show differences associated with socio-
demographic factors in these populations.
Males, young adults, persons living in the countryside
and those persons working in the healthcare sector were
significantly more likely to be S. aureus carriers. Rural
areas demonstrated a clear association with S. aureus
carrier status, even when adjusting for GP practice. This
is likely a consequence of members of rural communities
having more contact with S. aureus. Rural areas include
those with farmland, which may suggest a higher expos-
ure to the influence of livestock breeding. This has pre-
viously been described in literature as a risk factor for S.
aureus carrier and resistance carrier status [12–15].
However, interestingly, livestock workers did not demon-
strate a higher prevalence of carrier status in our ana-
lysis, though this could be due to the small sample size
of this subgroup. It was additionally recognized that
males are more likely to be S. aureus carriers, with an
OR of 1.60 compared to women. This result is supported
by other studies that have also observed higher S. aureus
carriage in men [22]. Possible reasons for this finding in-
clude host genetics or human innate immune factors,
smoking status, or vitamin D levels [39–41].
Table 2 Regression model for S. aureus carriers, carriers with resistances, and carriers with resistances besides PEN adjusted for GP
practices
S. aureus carrier S. aureus carrier
with resistances
S. aureus carrier with
resistances besides PEN
Variable Subvariable OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Sex Female 1.0 1.0 1.0
Male 1.60 (1.32–1.95) <0.001 0.81 (0.56–1.19) 0.283 0.93 (0.64–1.35) 0.709
Age 4–18 1.54 (0.86–2.75) 0.148 1.17 (0.43–3.16) 0.764 0.61 (0.21–1.78) 0.365
19–39 1.34 (1.02–1.77) 0.038 1.36 (0.78–2.35) 0.276 1.58 (0.91–2.74) 0.105
40–64 1.17 (0.90–1.51) 0.235 1.08 (0.65–1.77) 0.773 1.06 (0.65–1.73) 0.820
65+ 1.0 1.0 1.0
Location of residence Urban 1.0 1.0 1.0
Rural 1.37 (1.12–1.67) 0.002 1.27 (0.86–1.90) 0.232 1.53 (1.02–2.30) 0.041
Job Healthcare 1.47 (1.02–2.13) 0.041 0.94 (0.46–1.92) 0.857 0.84 (0.42–1.67) 0.615
Livestock farming 0.79 (0.45–1.40) 0.418 0.65 (0.23–1.86) 0.423 0.54 (0.19–1.55) 0.250
Kindergarten teacher/nanny 0.63 (0.27–1.50) 0.297 2.13 (0.25–18.20) 0.489 2.63 (0.29–23.68) 0.389
Not known 0.71 (0.48–1.03) 0.067 0.95 (0.47–1.94) 0.895 0.80 (0.39–1.65) 0.545
Others 1.0 1.0 1.0
Nagelkerkes R2 0.050 0.074 0.066
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Compared to other professions, healthcare workers were
found to have a greater likelihood to be S. aureus carriers
(OR of 1.47). This finding is not surprising, given the regu-
lar exposure and proximity of healthcare workers to vari-
able and resistant strains of microbials in hospital and
ambulatory settings. However, it does offer important im-
plications for healthcare workers and the health care sys-
tem. In the consultation setting, healthcare workers should
be considered to have a higher likelihood to carry S. aureus
strains and an increased chance to transfer these to their
patients. Therefore, hand-hygiene following patient contact
is essential to hinder the transfer [42].
Nearly 30 % of S. aureus strains identified were suscep-
tible to all antibiotics tested. The vast majority (64.8 %) of
commensal S. aureus strains was resistant to small-
spectrum PEN, followed by the macrolide antibiotics
AZITH and ERY as well as CLIND, with a resistance rate
around 12 %. Comparing these findings to those in other
European countries, it becomes clear that Austria is nearly
average in terms of prevalence rates when compared to
other European nations [8]. As it is recognized that one of
the corner stones for the containment of AR is the appro-
priate prescription of antibiotics in the outpatient sector
[28], this finding could support to the avoidance of pre-
scription of broad-spectrum antibiotics to treat S. aureus
infections in the community. This is because of low levels
of resistance in these settings, aside from PEN resistances
in ambulatory populations.
With regard to the overall resistances of the S. aureus
strains carried, no associations with socio-demographics
were directly identified. However, for the S. aureus
strains that were resistant to antibiotics besides PEN, as-
sociations with living in rural areas could be found. This
goes in line with the S. aureus carriers that were more
frequently found in rural areas. In contrast, multi-drug
resistances were observed more often in individuals liv-
ing in urban areas. The higher rates of multi-drug resist-
ant S. aureus strains in individuals living in urban areas
could be a consequence of higher travel activity com-
pared to those living in rural areas [11]. It could add-
itionally be surmised that persons living in urban areas
have easier access to ambulatory or hospital sectors, and
thus have a higher likelihood to present for even simple
conditions, such as a common cold. Due to the fact that
Austria has no gatekeeping system in primary care, pa-
tients may access care at any point and as often as they
wish. Thus, these patients could have a higher probabil-
ity of being exposed to antibiotics [43]. In line with this,
Hoffmann et al. found that in Eastern Austria, approxi-
mately one third of persons that do not get an antibiotic
prescription from the GP will subsequently present to a
specialist to receive one [44].
In this study with participants without infectious diseases,
we observed low rates of MRSA in Austria, with only 1.5 %
of S. aureus carriers having MRSA. An important finding of
Table 3 Number of resistances of S. aureus against AB
(except MRSA) (n = 541)
Nr. of res. Percent (n) AB resistance ranked by frequency
in percent (n)
0 30.3 (164) -
1 53.3 (288) 97.6 (281) PEN, 1.4 (4) TETRA, 0.7
(2) GENTA, 0.3 (1) CIP
2 3.3 (18) 83.3 (15) PEN, 44.4 (8) TETRA,
38.9 (7) GENTA, 22.2 (4) CIP, 5.6
(1) AZITH, 55.6 (1) ERY
3 4.6 (25) 96.0 (24) AZITH, 92.0 (23) ERY,
64.0 (16) CLIND, 32.0 (8) PEN, 8.0
(2) CIP, 3.8 (1) GENTA, 4.0 (1) TETRA,
4.0 (1) TRISUL
4 8.1 (44) 100.0 (44) ERY, 100.0 (44) AZITH,
95.5 (42) PEN, 95.5 (42) CLIND, 4.5
(2) GENTA, 4.5 (2) TETRA
5 0.4 (2) 100.0 (2) ERY, 100.0 (2) AZITH,
100.0 (2) TETRA, 100.0 (2) PEN,
100.0 (2) CLIND
Table 4 Number of resistances of S. aureus against AB besides
PEN (n = 356)
Nr. of res. Percent (n) AB resistance ranked by frequency
in percent (n)
79.0 (281) PEN 100.0 (281)
1 5.0 (18) + CIP 22.2 (4), GENTA 27.8 (5), OXA
16.7 (3), TETRA 33.3 (6)
2 2.5 (9) + AZITH 77.8 (7), CIP 11.1 (1), ERY
77.8 (7), GENTA 11.1 (1), OXA 11.1
(1), TETRA 11.1 (1)
3 12.0 (43) + AZITH 100.0 (43), CLIND 95.3 (41),
ERY 100.0 (43), GENTA 2.3 (1), OXA
2.3 (1)
4 0.8 (3) + AZITH 100.0 (3), CLIND 66.7 (2),
ERY 100.0 (3), OXA 33.3 (1), TETRA
100.0 (3)
5 0.6 (2) + AZITH 100.0 (2), CIP 50.0 (1), CLIND
100.0 (2), ERY 100.0 (2), OXA 100.0 (2),
TETRA 50.0 (1)
Table 5 Number of resistances of MRSA strains in addition to
PEN and OXA (n = 8)
Nr. of res. Percent (n) AB resistance ranked by
frequency in percent (n)
37.5 (3) OXA & PEN 100.0 (3)
1 12.5 (1) + GENTA 100.0 (1)
2 12.5 (1) + AZITH 100.0 (1) + ERY
100.00 (1)
3 12.5 (1) + AZITH 100.0 (1) + ERY
100.0 (1) + TETRA 100.0 (1)
4 25.0 (2) + AZITH 100.0 (2) + CIP 50.0
(1) + CLIND 100.0 (2) + ERY
100.0 (2) + TETRA 50.0 (1)
Hoffmann et al. BMC Infectious Diseases  (2015) 15:213 Page 6 of 9
our study is that there exists a difference among the MRSA
rates previously examined in hospital samples and those
samples from sick patients presenting to the ambulatory
sector with a bacterial infectious disease. For example, in
Austria in 2013, the Austrian resistance report stated that
hospitalized patients were found to have invasive (blood
and cerebrospinal fluid) MRSA strains with a prevalence of
9.1 %, and non-invasive MRSA strains in 6.7 % of cases
studied. Meanwhile, non-invasive MRSA strains were de-
tected from sick persons in the outpatient sector with a
prevalence of 4.0 % [21].
If S. aureus strains were resistant to three or more an-
tibiotics, we observed that nearly all of these were resist-
ant to PEN, AZITH, ERY, and CLIND (Table 3, Table 4
and Table 5). This has profound and practical implica-
tion for care of patients in Austria, particularly as pre-
scribers can look to utilize other antibiotics in patient
populations with high likelihood for multiple resistances.
Strength and limitations
A strength of the present study was the community setting
in which patients were drawn from a GP population who
visited the practice for a non-infectious reason. This is par-
ticularly important as no previous study of depth has been
carried out in this population. Another strength was the
large sample size and the similarity of the sample with the
Austrian population with regard to sex, age and educational
level [45]. However, as the study population has been re-
cruited in general practices we lacked participants among
those that otherwise did not present to a GP within this
time frame. Other limitations were the non-randomized re-
cruitment strategy of GPs and patients and the fact that the
questionnaire was available exclusively in German. It may
be speculated that more GPs and patients interested in the
topic of AR participated in the study, which would have led
to an underestimation of the real resistance pattern of
antibiotics, especially, regarding non-German speaking
migrants. Finally, socio-demographic factors explain only
about 5 % of variance of the S. aureus prevalence and re-
sistance rates, suggesting that other factors such as host
genetics or human innate immune factors, smoking status,
vitamin D levels, travel activities, or exposure to antibi-
otics may play a role as well. As this study is cross-
sectional there is limitation to the explanatory power.
Table 6 Distribution of the socio-demographic variables in relation to the number of antibiotics resistant to S. aureus (except MRSA)
Variable Sub-variable Number of antibiotics
resistant to S. aureus
p-value
0 1 2 3+
% (n) % (n) % (n) % (n)
Sex Female 27.8 (70) 52.4 (132) 4.8 (12) 15.1 (38) 0.175
Male 31.8 (91) 54.5 (156) 2.1 (6) 11.5 (33)
Age 4–18 28.6 (8) 46.4 (13) 0 25.0 (7)
19–39 26.5 (43) 61.7 (100) 2.5 (4) 9.3 (15) 0.224
40–64 31.9 (79) 50.0 (124) 3.6 (9) 14.5 (36)
65+ 33.0 (34) 50.5 (52) 4.9 (5) 11.7 (12)
Educational level Primary 30.6 (81) 56.6 (150) 3.8 (10) 9.1 (24)
Secondary 31.4 (60) 51.3 (98) 1.6 (3) 15.7 (30) 0.127
Tertiary 31.4 (22) 45.7 (32) 5.7 (4) 17.1 (12)
Country of origin Austria 31.5 (145) 52.7 (243) 2.8 (13) 13.0 (60)
EU 15+ 22.7 (5) 54.5 (12) 4.5 (1) 18.2 (4) 0.748
New EU 28 25.0 (4) 56.3 (9) 6.3 (1) 12.5 (2)
Others 25.0 (9) 58.3 (21) 8.3 (3) 8.3 (3)
Location of residence Urban 33.3 (66) 44.9 (89)a 4.0 (8) 17.7 (35)a 0.014
Rural 28.5 (98) 58.1 (200)b 2.9 (10) 10.5 (36)b
Job Health care 30.8 (12) 46.2 (18) 5.1 (2) 17.9 (7)
Livestock farming 37.5 (6) 43.8 (7) 6.3 (1) 12.5 (2)
Kindergarten teacher/nanny 14.3 (1) 57.1 (4) 0 28.6 (2) 0.926
Others 29.9 (128) 54.9 (235) 3.0 (13) 12.1 (52)
Not known 32.7 (17) 48.1 (25) 3.8 (2) 15.4 (8)
a,bThe subscript letters represent a subset of the variable category which is not significantly different at a significance level of p < 0.05 if it is the same subscript for the
same sub-variable
Significance at significance level of p < 0.005
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Conclusion
Emergence of increasingly resistant strains of microbials
has been recognized by the WHO and others as a global
health threat. AR is heavily influenced by dynamics that
occur outside of hospital settings, such as prescribing
patterns and livestock breeding. Despite this, the major-
ity of studies of AR in Europe have occurred in hospital-
ized patients or sick ambulatory patients presenting with
bacterial infections. This study, in contrast, describes the
prevalence and resistance pattern of commensal S. aur-
eus in community-dwelling GP patients in Austria and
shows differences between socio-demographic groups.
Particularly, differences were identified in the prevalence
and multi-drug resistances of commensal S. aureus be-
tween the sexes and individuals living in rural and urban
areas in Austria. More than two thirds of all S. aureus
carriers had resistant strains, though the vast majority
was resistant against small-spectrum PEN only. Physi-
cians should consider these findings when determining
therapeutic options with antibiotics. Particularly, this
finding could lend support to the avoidance of prescrip-
tion of broad-spectrum antibiotics to treat S. aureus in-
fections in rural community settings.
As we continue to witness a global rise in AR, it is im-
perative that acknowledged patterns of resistance are ac-
curate and reflect true prevalence at the community level.
Responding to outbreaks in resistant strains will require
an understanding of social and demographic factors as
well. We urge the further study of communities and,
otherwise healthy, populations in order to continue to
elucidate representative prevalence and resistance patterns.
Ideally, continual surveillance of resistance patterns and
antibiotic consumption in the outpatient setting should be
carried out to detect changes early and to inform evidence-
based decisions in a timely manner.
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